Figures and data
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_fig1.tif/full/max/0/default.jpg)
Flowchart of the inclusion criteria. ERCP, endoscopic retrograde cholangiopancreatography.
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl1.tif/full/max/0/default.jpg)
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl1a.tif/full/max/0/default.jpg)
Comparison of patient characteristics and ERCP outcomes between the development and validation cohorts.
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl2.tif/full/max/0/default.jpg)
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl2a.tif/full/max/0/default.jpg)
Logistic regression analysis of predictive factors for PEP in the development cohort.
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl3.tif/full/max/0/default.jpg)
Patient distribution in terms of risk score and classification.
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_tbl4.tif/full/max/0/default.jpg)
Goodness of fit of the risk score model.
![](https://prod--epp.elifesciences.org/iiif/2/101604%2Fv1%2Fcontent%2F24311807v1_fig2.tif/full/max/0/default.jpg)
Example of the preprocedural PEP risk checklist. ERCP, endoscopic retrograde cholangiopancreatography. IPMN, intraductal papillary mucinous neoplasm; PEP, post-ERCP pancreatitis.